Urolithin A increases the natural killer activity of PBMCs in patients with prostate cancer

Urolithin A increases the natural killer activity of PBMCs in patients with prostate cancer

BackgroundThe natural killer (NK) activity of peripheral blood mononuclear cells (PBMCs) is a crucial defense against the onset and spread of cancer. Studies have shown that patients with reduced NK activity are more susceptible to cancer, and NK activity tends to decrease due to cancer-induced immu...

Full description

Saved in:

Bibliographic Details
Main Authors:	Vladimir Rogovskii, Vladimir V. Murugin, Nikolay Vorobyev, Sergey Popov, Nikolay Sturov, Alexey Krasheninnikov, Alexander Morozov, Marina Prokhorova
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Pharmacology
Subjects:	urolithin A natural killer activity PBMCs prostate cancer computational prediction
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1503317/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Expression of toll-like receptors (tlrs) in the equine peripheral blood mononuclear cells (pbmcs) during the early pregnancy and estrous cycle
by: Ercan Kurar, et al.

Computational Study of Some Urolithin Derivatives-based Biomass Corrosion Inhibitors on the Fe (110), Cu(111) and Al(111) Surface
by: Rebaz A. Omer
Published: (2025-02-01)

Efficacy of natural killer T and gammadelta T cells in mesothelin-targeted immunotherapy of pancreatic cancer
by: Yuankui Zhu, et al.
Published: (2025-02-01)

PBMCs gene expression predicts liver fibrosis regression after successful HCV therapy in HIV/HCV-coinfected patients
by: Ana Virseda-Berdices, et al.
Published: (2025-01-01)

Sino-noir of Serial Killers and Dismemberments
by: Sheng-mei Ma
Published: (2024-12-01)

Contradictory Effect of Lymphocyte Therapy and Prednisolone Therapy on CD3+CD8+CD56+ Natural Killer T Population in Women with Recurrent Spontaneous Abortion
by: Fatemeh Rezayat, et al.
Published: (2023-07-01)

Exosomal PVRL4 Promotes Lung Adenocarcinoma Progression by Enhancing the Generation of Myeloid‐Derived Suppressor Cell‐Secreted TGF‐β1
by: Yahai Liang, et al.
Published: (2025-01-01)

Interventional factors influencing natural killer cell immunity in colorectal cancer: a systematic review
by: Wai Sinn Soh, et al.
Published: (2025-02-01)

Syngeneic natural killer cell therapy activates dendritic and T cells in metastatic lungs and effectively treats low-burden metastases
by: Shih-Wen Huang, et al.
Published: (2025-01-01)

Profiles of Killer Systems and Volatile Organic Compounds of Rowanberry and Rosehip-Inhabiting Yeasts Substantiate Implications for Biocontrol
by: Iglė Vepštaitė-Monstavičė, et al.
Published: (2025-01-01)

Single-cell RNA sequencing highlights the role of distinct natural killer subsets in sporadic amyotrophic lateral sclerosis
by: Esther Álvarez-Sánchez, et al.
Published: (2025-01-01)

Current status of cytokine-induced killer cells and combination regimens in breast cancer
by: Yuancong Jiang, et al.
Published: (2025-02-01)

Revealing the role of natural killer cells in ankylosing spondylitis: identifying diagnostic biomarkers and therapeutic targets
by: Yuling Chen, et al.
Published: (2025-12-01)

Incidence of prostate adenocarcinoma in transurethral resection of the prostate patients
by: Yahia Ghazwani, et al.
Published: (2025-01-01)

Trying to Kill a Killer; Impressive Killing of Patient Derived Glioblastoma Cultures Using NK-92 Natural Killer Cells Reveals Both Sensitive and Highly Resistant Glioblastoma Cells
by: Jane Yu, et al.
Published: (2025-01-01)

Current biomarkers of prostate cancer
by: I. A. Aboian, et al.
Published: (2021-12-01)

Targeting Caveolin‐1 in Multiple Myeloma Cells Enhances Chemotherapy and Natural Killer Cell‐Mediated Immunotherapy
by: Dewen Zhan, et al.
Published: (2025-01-01)

CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma
by: Laura M. Moser, et al.
Published: (2025-02-01)

The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate Biopsy
by: Ugo Giovanni Falagario, et al.
Published: (2025-01-01)

Association between prostate-specific antigen density and prostate cancer prediction among Nigerian men
by: Abudu EK, et al.
Published: (2025-01-01)

A New Antibody–Cytokine Construct Targeting Natural Killer Cells: An Immunotherapeutic Approach to Chronic Lymphocytic Leukemia
by: Michela Flego, et al.
Published: (2025-01-01)

IMPROVING THE QUALITY OF PROSTATE TRANSURETHRAL RESECTION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA THROUGH INTRAOPERATIVE TRANSRECTAL ULTRASOUND MONITORING OF THE REMOVED TISSUE VOLUME
by: V. B. Filimonov, et al.
Published: (2019-06-01)

A case of stromal sarcoma of the prostate with the incidental detection of prostate adenocarcinoma
by: Shang Xu, et al.
Published: (2025-03-01)

Potential clinical application of the cancer antigen CA‑62 for differential diagnosis of prostate cancer and benign prostatic hyperplasia at the elevated prostate‑specific antigen
by: Zh. R. Cherkasova, et al.
Published: (2023-03-01)

The factors impacting on Gleason score upgrading in prostate cancer with initial low Gleason scores
by: Tzu-Heng Huang, et al.
Published: (2025-02-01)

Tracing Atlantic Water Signature in the Arctic Sea Ice Cover East of Svalbard
by: Vladimir V. Ivanov, et al.
Published: (2012-01-01)

Prostatic Artery Embolization: A Systematic Review Article
by: Pooja Atkuri, et al.
Published: (2025-01-01)

Analysis of the predictive value of the prostate-specific antigen-to-neutrophil ratio for the diagnosis of prostate cancer
by: Yuxuan Chen, et al.
Published: (2025-01-01)

A Rare Metastasis of Prostate Cancer
by: İlkin Hamid-Zada, et al.
Published: (2024-07-01)

Prostate Cancer Screening: Is it Recommended in 2024?
by: Dr. Ali Thwaini
Published: (2024-12-01)

Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases
by: Dae Yul Yang, et al.
Published: (2025-01-01)

The “prostate-pelvic syndrome” theory used in patients with type-III prostatitis and its correlation with prostate volume
by: Xiao-Ma Zhang, et al.
Published: (2025-01-01)

Malondialdehyde in benign prostate hypertrophy: a useful marker?
by: Rosaria Alba Merendino, et al.
Published: (2003-01-01)

HYDRODISSECTION FOR PRESERVATION OF NEUROVASCULAR BUNDLE DURING RADICAL PROSTATECTOMY
by: H. S. Gevorgyan, et al.
Published: (2016-12-01)

Correlation of clinically significant prostate cancer sites across multiparametric MRI, prostate biopsy, and whole-mount pathology for optimal prostate biopsy strategy
by: Matteo Pacini, et al.
Published: (2025-02-01)

First record of a fossil spittlebug (Hemiptera: Auchenorrhyncha: Aphrophoridae) in Miocene deposits in Bulgaria
by: Radost Angelova, et al.
Published: (2025-02-01)

New Approach Methodologies (NAMs) to assess killer whale (Orcinus orca) estrogen receptor alpha (ERα) transactivation potencies by DDTs and their risks
by: Dave Arthur R. Robledo, et al.
Published: (2025-02-01)

COMPREHENSIVE TREATMENT OF PATIENTS WITH PROSTATITIS FROM THE VIEWPOINT OF MODERN REQUIREMENTS
by: H.V. Bachurin
Published: (2017-03-01)

RADIUM-223. PLACE IN THE TREATMENT OF METASTATIC CASTRATION-REFRACTORY PROSTATE CANCER
by: A. A. Kostin, et al.
Published: (2017-12-01)

Influence of Regular Statin Intake on Prostate‐Specific Antigen Values, Prostate Cancer Incidence and Overall Survival in a Prospective Screening Trial (ERSPC Aarau)
by: Alkiviadis Papagiannakis, et al.
Published: (2025-01-01)